The CO breath test monitors market is a critical segment of the medical diagnostics industry, providing essential tools for non-invasive testing of gastrointestinal disorders, respiratory diseases, and other health conditions. These monitors detect carbon monoxide (CO) and other gases in exhaled breath, enabling healthcare providers to diagnose conditions like lactose intolerance, small intestinal bacterial overgrowth, Helicobacter pylori infection, and respiratory disorders without invasive procedures. With rising prevalence of gastrointestinal disorders, increasing demand for non-invasive testing, and technological advancements in breath analysis, this market is experiencing robust growth.

The market was valued at USD 800 million in 2024, about USD 800 million in 2025, and is projected to reach roughly USD 1,500 million by 2035, growing at a CAGR of approximately 5.9%. Growth is driven by rising prevalence of gastrointestinal disorders, increasing demand for non-invasive testing, technological advancements in monitoring devices, growing awareness for preventive healthcare, and expanding healthcare infrastructure in emerging markets.

By application, medical diagnostics hold the largest share (valued at USD 350 million in 2024 and projected to reach USD 650 million by 2035), reflecting the rising awareness surrounding respiratory diseases and the increasing prevalence of conditions requiring effective monitoring solutions. Research and development, clinical trials, and patient monitoring also contribute significantly, each driven by strong growth in validating new medical treatments, pushing the boundaries of scientific exploration, and continuous monitoring for chronic disease management.

By product type, portable monitors are gaining traction due to their convenience and suitability for home use. Desktop monitors continue to serve traditional clinical settings, while handheld monitors are emerging as a versatile option for on-the-go testing.

By end user, hospitals are major players, leveraging advanced diagnostic tools and technologies to improve patient outcomes. Diagnostic laboratories, research institutions, and homecare settings also contribute, each playing a critical role in providing essential testing services, pushing the boundaries of diagnostic methods, and offering convenient testing options for patients.

By technology, non-invasive sensors play a vital role due to their ability to provide accurate and quick results without the discomfort associated with traditional methods. Microbial analysis helps identify specific microbial activity, offering insights that are invaluable for diagnosing various gastrointestinal disorders. Analytical software supports the interpretation of complex data, enabling healthcare professionals to make informed decisions rapidly.

Regionally, North America leads, driven by advanced healthcare infrastructure and increasing awareness of diagnostic technologies. Europe follows with steady expansion, while Asia-Pacific is emerging rapidly, driven by increasing investments in healthcare technology and a rise in respiratory ailments.

Key players include Sierra Instruments, Echosens, Alere Inc, Beacon Diagnostics, Abbott Laboratories, Respire Medical, Medtronic, Draegerwerk AG, Helium Health, Quidel Corporation, Simbiosys, Thermo Fisher Scientific, F. Hoffmann-La Roche AG, GastroSoft, and LUMEDX. Strategies focus on developing innovative breath test monitors, integrating AI and machine learning, and forming strategic partnerships.

Read more: Global Co-Breath Test Monitors Market Research Report

People Also Ask

Q1. What are CO breath test monitors used for?
CO breath test monitors are used for non-invasive testing of gastrointestinal disorders, respiratory diseases, and other health conditions, detecting carbon monoxide and other gases in exhaled breath to diagnose conditions like lactose intolerance, H. pylori infection, and respiratory disorders without invasive procedures.

Q2. Which region leads the CO breath test monitors market?
North America leads due to advanced healthcare infrastructure and increasing awareness of diagnostic technologies, while Asia-Pacific is emerging rapidly, driven by increasing investments in healthcare technology and a rise in respiratory ailments.

Tags: CO breath test monitor, non-invasive testing, gastrointestinal disorders, respiratory diseases, medical diagnostics, breath analysis